Gyre Therapeutics
GYRE
GYRE
70 hedge funds and large institutions have $85.6M invested in Gyre Therapeutics in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 31 increasing their positions, 13 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
10% less capital invested
Capital invested by funds: $95.2M → $85.6M (-$9.58M)
24% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 17
80% less call options, than puts
Call options by funds: $679K | Put options by funds: $3.41M
Holders
70
Holding in Top 10
1
Calls
$679K
Puts
$3.41M
Top Buyers
| 1 | +$2.76M | |
| 2 | +$2.62M | |
| 3 | +$2.55M | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$1.75M |
| 5 |
Two Sigma Investments
New York
|
+$1.56M |
Top Sellers
| 1 | -$9.69M | |
| 2 | -$7.01M | |
| 3 | -$1.67M | |
| 4 |
Renaissance Technologies
New York
|
-$1.57M |
| 5 |
PE
Point72 Europe
London,
United Kingdom
|
-$974K |